clinical trials

Briggs Morrison’s little biotech Syndax concedes 2 key trial setbacks for its lead drug, as shares shrivel some more
Briggs Morrison’s little biotech Syndax concedes 2 key trial setbacks for its lead drug, as shares shrivel some more
Endpoints
Syndax
Briggs Morrison
clinical trials
entinostat
Flag link:
‘Brutal disaster.’ Allergan’s would-be antidepressant fails patients in four studies
‘Brutal disaster.’ Allergan’s would-be antidepressant fails patients in four studies
Stat
Allergan
antidepressants
repastinel
clinical trials
Flag link:
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
BioPharma Dive
Gilead Sciences
HIV
Descovy
Truvada
clinical trials
Flag link:
Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3
Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3
Xconomy
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-445
Symdeko
Flag link:
Ascendis jumps on Phase III readout for once-weekly growth hormone
Ascendis jumps on Phase III readout for once-weekly growth hormone
BioCentury
Ascendis
TransCon hGH
pediatric growth hormone deficiency
clinical trials
Flag link:
After nebulizer flop, Verona touts interim PhII results on another version of its lead COPD drug
After nebulizer flop, Verona touts interim PhII results on another version of its lead COPD drug
Endpoints
Verona
clinical trials
ensifentrine
COPD
Flag link:
Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Motley Fool
Novavax
RSV
vaccines
FDA
clinical trials
Flag link:
ImmunoGen Plunges After Phase III Ovarian Cancer Treatment Fails to Hit PFS Endpoint
ImmunoGen Plunges After Phase III Ovarian Cancer Treatment Fails to Hit PFS Endpoint
BioSpace
Immunogen
ovarian cancer
clinical trials
mirvetuximab soravtansine
Flag link:
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Endpoints
RSV
vaccines
Novavax
clinical trials
Flag link:
Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Pharmaforum
Sanofi
Regeneron
Dupixent
clinical trials
nasal polyps
Flag link:
AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer
AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer
Endpoints
AstraZeneca
Merck
pancreatic cancer
clinical trials
BRCA-mutated prostate cancer
Flag link:
Can Roche’s little tech startup help the FDA change clinical trials?
Can Roche’s little tech startup help the FDA change clinical trials?
Stat
FDA
Roche
clinical trials
Flatiron Health
Flag link:
AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study
AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study
Endpoints
AstraZeneca
Brilinta
diabetes
blood thinner
clinical trials
Flag link:
Intercept stock drop reflects the high bar set for NASH drugs
Intercept stock drop reflects the high bar set for NASH drugs
BioPharma Dive
Intercept Pharma
Ocaliva
NASH
clinical trials
Flag link:
40 Sites Across The Country To Test New Alzheimer's Drug
40 Sites Across The Country To Test New Alzheimer's Drug
Forbes
clinical trials
Alzheimer's disease
troriluzole
Biohaven
Flag link:
Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light
Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light
Endpoints
Merck
Keytruda
clinical trials
liver cancer
Flag link:
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
BioSpace
NASH
Intercept Pharmaceuticals
obeticholic acid
OCA
clinical trials
Flag link:
Higher dose of Pfizer-Lilly drug helps reduce back pain in study
Higher dose of Pfizer-Lilly drug helps reduce back pain in study
Yahoo/Reuters
Pfizer
Eli Lilly
chronic low back pain
low back pain
clinical trials
tanezumab
opioid alternatives
Flag link:
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Boehringer Ingelheim
Eli Lilly
glimepiride
linagliptin
Tradjenta
type 2 diabetes
clinical trials
Flag link:
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
BioPharma Dive
Merck
Keytruda
prostate cancer
clinical trials
Flag link:

Pages